D-0559-2022 Class II Ongoing

Recalled by Organics Corporation Of America DBA Ambix Laboratories — Totowa, NJ

FDA drug recall D-0559-2022 was initiated by Organics Corporation Of America DBA Ambix Laboratories on Dec 6, 2021 and is designated Class II. Reason for recall: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter gergoviae. The recall status is ongoing. Affected quantity: 4,214 tubes.

Recall details

Product Type
Drugs
Report Date
Feb 23, 2022
Initiation Date
Dec 6, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,214 tubes

Product description

NaturesPlus Advanced Therapeutics Glucosamine Chondroitin MSM Ultra Rx- Joint Cream, 4 oz tubes, Manufactured for NaturesPlus 548 Broadhollow Road, Melville, NY 11747, USA

Reason for recall

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter gergoviae.

Distribution pattern

The product went to one consignee. Natural Organics, Inc., 548 Broadhollow Rd., Melville, NY 11747.

Code information

Product code 4929, Lot # 23622

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0559-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0559-2022. Report a data issue: hello@regdatalab.com.